Drug treatment approved for equine neurological disease.
D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D017277:Drug Approval; D004679:Encephalomyelitis / Q000188:drug therapy / Q000469:parasitology / Q000662:veterinary*; D006734:Horse Diseases / Q000188:drug therapy* / Q000469:parasitology; D006736:Horses; D012522:Sarcocystis / Q000302:isolation & purification*; D012523:Sarcocystosis / Q000188:drug therapy / Q000469:parasitology / Q000662:veterinary*; D014227:Triazines / Q000627:therapeutic use*
D000981:Antiprotozoal Agents; D014227:Triazines; C415002:ponazuril